These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10613787)

  • 1. Pharmacotherapy of asthma in children, with special reference to leukotriene receptor antagonists.
    Weisberg SC
    Pediatr Pulmonol; 2000 Jan; 29(1):46-61. PubMed ID: 10613787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of leukotriene antagonists in childhood asthma.
    Krawiec ME; Wenzel SE
    Curr Opin Pediatr; 1999 Dec; 11(6):540-7. PubMed ID: 10590913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileukotrienes in asthma: present situation.
    García-Marcos L; Schuster A
    Expert Opin Pharmacother; 2001 Mar; 2(3):441-66. PubMed ID: 11336598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the management of asthma using leukotriene modifiers.
    Kemp JP
    Am J Respir Med; 2003; 2(2):139-56. PubMed ID: 14720013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New perspectives for asthma treatment: anti-leukotriene drugs.
    García-Marcos L; Schuster A
    Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene-receptor antagonists.
    Lipworth BJ
    Lancet; 1999 Jan; 353(9146):57-62. PubMed ID: 10023966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileukotriene drugs in the treatment of asthma.
    Mastalerz L; Kumik J
    Pol Arch Med Wewn; 2010 Mar; 120(3):103-8. PubMed ID: 20332717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic advances: leukotriene antagonists for the treatment of asthma.
    Misson J; Clark W; Kendall MJ
    J Clin Pharm Ther; 1999 Feb; 24(1):17-22. PubMed ID: 10319903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of antileukotriene agents in asthma therapy.
    Gawchik SM; Saccar CL
    J Am Osteopath Assoc; 2000 Jan; 100(1):32, 37-43. PubMed ID: 10693315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study on bronchial asthma and leukotriene antagonists].
    Yokoyama A
    Nihon Naika Gakkai Zasshi; 2004 Dec; 93(12):2656-61. PubMed ID: 15658499
    [No Abstract]   [Full Text] [Related]  

  • 12. Asthma treatment: antileukotriene drugs.
    O'Byrne PM
    Can Respir J; 1998; 5 Suppl A():64A-70A. PubMed ID: 9753521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood.
    Warner JO
    Allergy; 2001; 56 Suppl 66():22-9. PubMed ID: 11421938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors].
    Diamant Z; Sterk PJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(5):72-8. PubMed ID: 12013053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.
    Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R
    Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
    Bisgaard H
    Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
    Adkins JC; Brogden RN
    Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene modifiers in pediatric asthma management.
    Bisgaard H
    Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Montelukast in the treatment of mild to moderate persistent asthma].
    Bellecoste V; Devouassoux G; Pacheco Y
    Rev Mal Respir; 2011 Jun; 28(6):706-29. PubMed ID: 21742233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in therapy with antileukotriene drugs.
    Riccioni G; Di Ilio C; Conti P; Theoharides TC; D'Orazio N
    Ann Clin Lab Sci; 2004; 34(4):379-87. PubMed ID: 15648777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.